OTCMKTS:SIGY

Sigyn Therapeutics Stock Forecast, Price & News

$0.79

+0.21 (+36.21 %)

(As of 09/24/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.79

▼

$0.79

50-Day Range

$0.52

▼

$1.00

52-Week Range

$0.30

▼

$3.50

Volume500 shs

Average Volume3,014 shs

Market Capitalization$28.97 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive SIGY News and Ratings via Email

Sign-up to receive the latest news and ratings for Sigyn Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

About Sigyn Therapeutics

Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company, which focuses on the treatment of life-threatening inflammatory conditions that are precipitated by cytokine storm syndrome. The company was founded by James A. Joyce and Craig P. Roberts on December 15, 2014 and is headquartered in San Diego, CA.

Sigyn Therapeutics (OTCMKTS:SIGY) Stock Price Up 11.5%
September 10, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SIGY
Previous Symbol
CUSIPN/A
CIK1642159
Webwww.sigyntherapeutics.com
Phone(213) 457-3772
Employees2
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares36,672,000
Market Cap$28.97 million
Next Earnings Date11/15/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Sigyn Therapeutics.

0.0 Community Rank

Outperform Votes
Sigyn Therapeutics has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Sigyn Therapeutics has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Sigyn Therapeutics and other stocks. Vote “Outperform” if you believe SIGY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SIGY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Sigyn Therapeutics does not currently pay a dividend.
Dividend Growth
Sigyn Therapeutics does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sigyn Therapeutics insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Sigyn Therapeutics (OTCMKTS:SIGY) Frequently Asked Questions

What stocks does MarketBeat like better than Sigyn Therapeutics?: Wall Street analysts have given Sigyn Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sigyn Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
When is Sigyn Therapeutics' next earnings date?: Sigyn Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.
View our earnings forecast for Sigyn Therapeutics.
How were Sigyn Therapeutics' earnings last quarter?: Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) released its quarterly earnings results on Monday, August, 16th. The company reported ($0.02) EPS for the quarter.
View Sigyn Therapeutics' earnings history.
Who are Sigyn Therapeutics' key executives?: Sigyn Therapeutics' management team includes the following people:
James A. Joyce, Chairman, Chief Executive & Financial Officer
Craig P. Roberts, Chief Technology Officer
Eric Lynam, Head-Clinical Affairs
Who are some of Sigyn Therapeutics' key competitors?: Some companies that are related to Sigyn Therapeutics include Arecor Therapeutics (AREC), Verseon (VSN), Verona Pharma plc (VRP.L) (VRP), Ensysce Biosciences (ENSC), Tiziana Life Sciences (TILS), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), Medigene (MDG1), SkinBioTherapeutics (SBTX), Mereo BioPharma Group plc (MPH.L) (MPH), Helix BioPharma (HBP), 4basebio UK Societas (4BB), Microbix Biosystems (MBX) and ProMIS Neurosciences (PMN).
View all of SIGY's competitors.
What is Sigyn Therapeutics' stock symbol?: Sigyn Therapeutics trades on the OTCMKTS under the ticker symbol "SIGY."
How do I buy shares of Sigyn Therapeutics?: Shares of SIGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Sigyn Therapeutics' stock price today?: One share of SIGY stock can currently be purchased for approximately $0.79.
How much money does Sigyn Therapeutics make?: Sigyn Therapeutics has a market capitalization of $28.97 million.
How many employees does Sigyn Therapeutics have?: Sigyn Therapeutics employs 2 workers across the globe.
What is Sigyn Therapeutics' official website?: The official website for Sigyn Therapeutics is www.sigyntherapeutics.com.
How can I contact Sigyn Therapeutics?: The company can be reached via phone at (213) 457-3772.

This page was last updated on 9/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Sigyn Therapeutics Stock Forecast, Price & News

About Sigyn Therapeutics

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Sigyn Therapeutics (OTCMKTS:SIGY) Frequently Asked Questions

What stocks does MarketBeat like better than Sigyn Therapeutics?

When is Sigyn Therapeutics' next earnings date?

How were Sigyn Therapeutics' earnings last quarter?

Who are Sigyn Therapeutics' key executives?

Who are some of Sigyn Therapeutics' key competitors?

What is Sigyn Therapeutics' stock symbol?

How do I buy shares of Sigyn Therapeutics?

What is Sigyn Therapeutics' stock price today?

How much money does Sigyn Therapeutics make?

How many employees does Sigyn Therapeutics have?

What is Sigyn Therapeutics' official website?

How can I contact Sigyn Therapeutics?